AG˹ٷ

STOCK TITAN

[Form 3] Colgate-Palmolive Company Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Colgate-Palmolive (NYSE: CL) submitted a routine Form 3 � Initial Statement of Beneficial Ownership for newly reported insider John Hazlin, Chief Growth Officer.

The filing shows Hazlin directly owns 14,385 common shares and indirectly owns 5,382 shares through the company’s 401(k) plan, for a total of 19,767 shares of common stock. In addition, he holds five separate stock-option grants covering an aggregate 103,340 underlying shares with exercise prices ranging from $72.83 to $106.34 and expiration dates between 2028 and 2032. Vesting schedules are disclosed for each grant, generally becoming exercisable in one-third increments starting one year after the grant date.

No purchases, sales or other transactions occurred on the reported event date (06/16/2025); the form simply establishes Hazlin’s beneficial ownership under Section 16(a). The filing contains no financial results, strategic updates, or other material corporate events.

Colgate-Palmolive (NYSE: CL) ha presentato un normale Modulo 3 � Dichiarazione Iniziale di Proprietà Beneficiaria per il neo segnalato dirigente John Hazlin, Chief Growth Officer.

La dichiarazione mostra che Hazlin possiede direttamente 14.385 azioni ordinarie e indirettamente 5.382 azioni tramite il piano 401(k) dell’azienda, per un totale di 19.767 azioni ordinarie. Inoltre, detiene cinque distinti premi di stock option che coprono un totale di 103.340 azioni sottostanti con prezzi di esercizio compresi tra $72,83 e $106,34 e scadenze tra il 2028 e il 2032. Per ogni premio sono stati resi noti i piani di maturazione, che generalmente consentono l’esercizio in tre tranche di un terzo ciascuna, a partire da un anno dopo la data di assegnazione.

Non sono state effettuate compravendite o altre transazioni nella data dell’evento segnalato (16/06/2025); il modulo serve semplicemente a stabilire la proprietà beneficiaria di Hazlin ai sensi della Sezione 16(a). La dichiarazione non contiene risultati finanziari, aggiornamenti strategici o altri eventi aziendali rilevanti.

Colgate-Palmolive (NYSE: CL) presentó un Formulario 3 � Declaración Inicial de Propiedad Beneficiaria rutinario para el nuevo insider reportado John Hazlin, Chief Growth Officer.

La presentación muestra que Hazlin posee directamente 14,385 acciones ordinarias e indirectamente 5,382 acciones a través del plan 401(k) de la compañía, sumando un total de 19,767 acciones ordinarias. Además, tiene cinco concesiones separadas de opciones sobre acciones que cubren un total de 103,340 acciones subyacentes con precios de ejercicio que van desde $72.83 hasta $106.34 y fechas de vencimiento entre 2028 y 2032. Se revelan los planes de adquisición para cada concesión, generalmente permitiendo el ejercicio en incrementos de un tercio, comenzando un año después de la fecha de concesión.

No se realizaron compras, ventas u otras transacciones en la fecha del evento reportado (16/06/2025); el formulario simplemente establece la propiedad beneficiaria de Hazlin bajo la Sección 16(a). La presentación no contiene resultados financieros, actualizaciones estratégicas u otros eventos corporativos relevantes.

Colgate-Palmolive (NYSE: CL)� 새로 보고� 내부� John Hazlin, 최고 성장 책임�� 대� 정기적인 양식 3 � 최초 수익 소유� 신고�� 제출했습니다.

신고서에 따르� Hazlin은 직접적으� 14,385 보통�� 보유하고 있으�, 회사� 401(k) 플랜� 통해 간접적으� 5,382 �� 보유하여 � 19,767 �� 보통주를 소유하고 있습니다. 또한, 행사 가격이 $72.83에서 $106.34 사이이고 만료일이 2028년부� 2032� 사이� 5건의 별도 주식매수선택� 부�� 보유하고 있으�, � 103,340 기초 주식� 해당합니�. � 부여에 대� 권리확정 일정� 공개되어 있으�, 일반적으� 부여일로부� 1� 후부� 3분의 1� 행사� � 있습니다.

보고� 이벤� 날짜(2025� 6� 16�)에는 매수, 매도 또는 기타 거래가 없었으며, � 양식은 단순� Hazlin� 수익 소유권을 섹션 16(a)� 따라 확립하기 위한 것입니다. 제출서에� 재무 결과, 전략� 업데이트 또는 기타 중요� 기업 이벤트가 포함되어 있지 않습니다.

Colgate-Palmolive (NYSE : CL) a soumis un Formulaire 3 � Déclaration initiale de propriété bénéficiaire de routine pour le nouvel initié déclaré John Hazlin, Chief Growth Officer.

Le dépôt indique que Hazlin possède directement 14 385 actions ordinaires et indirectement 5 382 actions via le plan 401(k) de l’entreprise, pour un total de 19 767 actions ordinaires. De plus, il détient cinq attributions distinctes d’options d’achat d’actions couvrant un total de 103 340 actions sous-jacentes avec des prix d’exercice allant de 72,83 $ à 106,34 $ et des dates d’expiration comprises entre 2028 et 2032. Les calendriers d’acquisition sont divulgués pour chaque attribution, généralement exerçables par tranches d’un tiers à partir d’un an après la date d’attribution.

Aucun achat, vente ou autre transaction n’a eu lieu à la date de l’événement déclaré (16/06/2025) ; le formulaire établit simplement la propriété bénéficiaire de Hazlin conformément à la Section 16(a). Le dépôt ne contient aucun résultat financier, mise à jour stratégique ou autre événement d’entreprise important.

Colgate-Palmolive (NYSE: CL) reichte eine routinemäßige Formular 3 � Erste Erklärung über wirtschaftliches Eigentum für den neu gemeldeten Insider John Hazlin, Chief Growth Officer ein.

Die Einreichung zeigt, dass Hazlin direkt 14.385 Stammaktien besitzt und indirekt 5.382 Aktien über den 401(k)-Plan des Unternehmens hält, was insgesamt 19.767 Stammaktien ergibt. Zusätzlich hält er fünf separate Aktienoptionszuteilungen, die insgesamt 103.340 zugrundeliegende Aktien umfassen, mit Ausübungspreisen von 72,83 bis 106,34 US-Dollar und Ablaufdaten zwischen 2028 und 2032. Für jede Zuteilung werden Vesting-Pläne offengelegt, die in der Regel in Drittelraten ab einem Jahr nach dem Zuteilungsdatum ausübbar werden.

Am gemeldeten Ereignisdatum (16.06.2025) fanden keine Käufe, Verkäufe oder sonstigen Transaktionen statt; das Formular dient lediglich dazu, Hazlins wirtschaftliches Eigentum gemäß Abschnitt 16(a) festzustellen. Die Einreichung enthält keine Finanzergebnisse, strategische Aktualisierungen oder sonstige wesentliche Unternehmensereignisse.

Positive
  • None.
Negative
  • None.

Colgate-Palmolive (NYSE: CL) ha presentato un normale Modulo 3 � Dichiarazione Iniziale di Proprietà Beneficiaria per il neo segnalato dirigente John Hazlin, Chief Growth Officer.

La dichiarazione mostra che Hazlin possiede direttamente 14.385 azioni ordinarie e indirettamente 5.382 azioni tramite il piano 401(k) dell’azienda, per un totale di 19.767 azioni ordinarie. Inoltre, detiene cinque distinti premi di stock option che coprono un totale di 103.340 azioni sottostanti con prezzi di esercizio compresi tra $72,83 e $106,34 e scadenze tra il 2028 e il 2032. Per ogni premio sono stati resi noti i piani di maturazione, che generalmente consentono l’esercizio in tre tranche di un terzo ciascuna, a partire da un anno dopo la data di assegnazione.

Non sono state effettuate compravendite o altre transazioni nella data dell’evento segnalato (16/06/2025); il modulo serve semplicemente a stabilire la proprietà beneficiaria di Hazlin ai sensi della Sezione 16(a). La dichiarazione non contiene risultati finanziari, aggiornamenti strategici o altri eventi aziendali rilevanti.

Colgate-Palmolive (NYSE: CL) presentó un Formulario 3 � Declaración Inicial de Propiedad Beneficiaria rutinario para el nuevo insider reportado John Hazlin, Chief Growth Officer.

La presentación muestra que Hazlin posee directamente 14,385 acciones ordinarias e indirectamente 5,382 acciones a través del plan 401(k) de la compañía, sumando un total de 19,767 acciones ordinarias. Además, tiene cinco concesiones separadas de opciones sobre acciones que cubren un total de 103,340 acciones subyacentes con precios de ejercicio que van desde $72.83 hasta $106.34 y fechas de vencimiento entre 2028 y 2032. Se revelan los planes de adquisición para cada concesión, generalmente permitiendo el ejercicio en incrementos de un tercio, comenzando un año después de la fecha de concesión.

No se realizaron compras, ventas u otras transacciones en la fecha del evento reportado (16/06/2025); el formulario simplemente establece la propiedad beneficiaria de Hazlin bajo la Sección 16(a). La presentación no contiene resultados financieros, actualizaciones estratégicas u otros eventos corporativos relevantes.

Colgate-Palmolive (NYSE: CL)� 새로 보고� 내부� John Hazlin, 최고 성장 책임�� 대� 정기적인 양식 3 � 최초 수익 소유� 신고�� 제출했습니다.

신고서에 따르� Hazlin은 직접적으� 14,385 보통�� 보유하고 있으�, 회사� 401(k) 플랜� 통해 간접적으� 5,382 �� 보유하여 � 19,767 �� 보통주를 소유하고 있습니다. 또한, 행사 가격이 $72.83에서 $106.34 사이이고 만료일이 2028년부� 2032� 사이� 5건의 별도 주식매수선택� 부�� 보유하고 있으�, � 103,340 기초 주식� 해당합니�. � 부여에 대� 권리확정 일정� 공개되어 있으�, 일반적으� 부여일로부� 1� 후부� 3분의 1� 행사� � 있습니다.

보고� 이벤� 날짜(2025� 6� 16�)에는 매수, 매도 또는 기타 거래가 없었으며, � 양식은 단순� Hazlin� 수익 소유권을 섹션 16(a)� 따라 확립하기 위한 것입니다. 제출서에� 재무 결과, 전략� 업데이트 또는 기타 중요� 기업 이벤트가 포함되어 있지 않습니다.

Colgate-Palmolive (NYSE : CL) a soumis un Formulaire 3 � Déclaration initiale de propriété bénéficiaire de routine pour le nouvel initié déclaré John Hazlin, Chief Growth Officer.

Le dépôt indique que Hazlin possède directement 14 385 actions ordinaires et indirectement 5 382 actions via le plan 401(k) de l’entreprise, pour un total de 19 767 actions ordinaires. De plus, il détient cinq attributions distinctes d’options d’achat d’actions couvrant un total de 103 340 actions sous-jacentes avec des prix d’exercice allant de 72,83 $ à 106,34 $ et des dates d’expiration comprises entre 2028 et 2032. Les calendriers d’acquisition sont divulgués pour chaque attribution, généralement exerçables par tranches d’un tiers à partir d’un an après la date d’attribution.

Aucun achat, vente ou autre transaction n’a eu lieu à la date de l’événement déclaré (16/06/2025) ; le formulaire établit simplement la propriété bénéficiaire de Hazlin conformément à la Section 16(a). Le dépôt ne contient aucun résultat financier, mise à jour stratégique ou autre événement d’entreprise important.

Colgate-Palmolive (NYSE: CL) reichte eine routinemäßige Formular 3 � Erste Erklärung über wirtschaftliches Eigentum für den neu gemeldeten Insider John Hazlin, Chief Growth Officer ein.

Die Einreichung zeigt, dass Hazlin direkt 14.385 Stammaktien besitzt und indirekt 5.382 Aktien über den 401(k)-Plan des Unternehmens hält, was insgesamt 19.767 Stammaktien ergibt. Zusätzlich hält er fünf separate Aktienoptionszuteilungen, die insgesamt 103.340 zugrundeliegende Aktien umfassen, mit Ausübungspreisen von 72,83 bis 106,34 US-Dollar und Ablaufdaten zwischen 2028 und 2032. Für jede Zuteilung werden Vesting-Pläne offengelegt, die in der Regel in Drittelraten ab einem Jahr nach dem Zuteilungsdatum ausübbar werden.

Am gemeldeten Ereignisdatum (16.06.2025) fanden keine Käufe, Verkäufe oder sonstigen Transaktionen statt; das Formular dient lediglich dazu, Hazlins wirtschaftliches Eigentum gemäß Abschnitt 16(a) festzustellen. Die Einreichung enthält keine Finanzergebnisse, strategische Aktualisierungen oder sonstige wesentliche Unternehmensereignisse.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Hazlin John

(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/16/2025
3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Growth Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 14,385 D
Common Stock 5,382 I By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 09/13/2031 Common Stock 19,342 $72.83 D
Stock Option (Right to Buy) (2) 09/10/2028 Common Stock 20,989 $76.41 D
Stock Option (Right to Buy) (3) 09/10/2029 Common Stock 23,376 $77.04 D
Stock Option (Right to Buy) (4) 09/09/2030 Common Stock 22,944 $78.03 D
Stock Option (Right to Buy) (5) 09/12/2032 Common Stock 16,689 $106.34 D
Explanation of Responses:
1. Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2023 grant date.
2. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
3. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.
4. Option became exercisable in one-third increments beginning on the first anniversary of the September 9, 2022 grant date.
5. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 12, 2024 grant date.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kristine Hutchinson, Attorney-in-Fact 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Colgate-Palmolive shares does Chief Growth Officer John Hazlin own?

According to the Form 3, Hazlin owns 19,767 common shares�14,385 held directly and 5,382 held indirectly via the company’s 401(k) plan.

What stock-option grants were reported for [[CL]]’s John Hazlin?

The filing lists five option grants covering 103,340 shares with exercise prices from $72.83 to $106.34, expiring 2028-2032.
Colgate Palmolive Co

NYSE:CL

CL Rankings

CL Latest News

CL Latest SEC Filings

CL Stock Data

68.76B
806.82M
0.16%
86.13%
1.68%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
United States
NEW YORK